Luspatercept
3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Luspatercept for anemia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Luspatercept for myelodysplastic syndromes | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Luspatercept for primary myelofibrosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |